ACT Enact Holdings, Inc. Insider Trading

Genworth Holdings (10% owner) sold 602,440 ACT shares at $42.91 on 2026-05-29; stock down 8.3% from 52-week high.

Genworth Holdings, a major 10% shareholder of Enact Holdings, executed a modest sale of 602,440 shares (representing -0.5% of pre-transaction holdings) at $42.91, above the current price of $41.09. At the same-ticker level, Genworth has conducted 5 prior sells at ACT with mixed timing: 2 of 5 achieved negative 90-day returns after the sale (well-timed), while 3 of 5 achieved positive 90-day returns (poorly timed). The cross-ticker track record shows an average 90-day return of +3.6% after Genworth's prior sells, indicating that historically this insider's sales have preceded stock rallies rather than declines. ACT itself is trading 8.3% below its 52-week high and down 3.5% over 30 days, providing context for the sale price relative to recent weakness but not definitively signaling a timing advantage.

Large 10% owner Genworth Holdings sells $23.8M stake in Enact Holdings amid modest price recovery.

Genworth Holdings, a substantial institutional holder with roughly one-tenth of Enact's shares outstanding, executed a large portfolio sale representing less than one-half percent of its total position. This is routine portfolio management by a fund rather than a signal of executive concern—Genworth has no operational role at Enact and its trading decisions reflect capital reallocation, not insider knowledge of deteriorating business conditions. The timing is unremarkable: Enact's stock has recovered modestly from its lows and is trading only slightly below its recent peak, a normal window for institutional rebalancing rather than a panic exit. With Enact posting solid profitability and modest revenue growth, and trading at a reasonable valuation multiple, the sale appears to be passive index rebalancing or opportunistic trimming of a large position rather than a vote of no confidence in the company's fundamentals.